Disparate molecular, histopathology, and clinical factors in head and neck squamous cell carcinoma racial groups

Otolaryngology - Head and Neck Surgery (United States)

Volumn 147, Issue 2, 2012, Pages 281-288

  Worsham, Maria J ^a   Stephen, Josena K ^a   Lu, Mei ^a   Chen, Kang Mei ^a   Havard, Shaleta ^a   Shah, Veena ^a   Schweitzer, Vanessa P ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

African American; Caucasian American; risk factor variables; tumor biology

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; DNA; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA;

ADULT; AFRICAN AMERICAN; AGED; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; EUROPEAN AMERICAN; FEMALE; GENE DOSAGE; GENE LOSS; GENETIC ASSOCIATION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HEALTH CARE ACCESS; HEALTH INSURANCE; HEALTH MAINTENANCE ORGANIZATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MEDICAID; MEDICARE; MOLECULAR PATHOLOGY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; RACE; RISK FACTOR; SMOKING; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; UNIVARIATE ANALYSIS; UNIVERSITY HOSPITAL; ARTICLE; CAUCASIAN; COMPARATIVE STUDY; GENETICS; HEAD AND NECK TUMOR; MIDDLE AGED; PATHOLOGY; SQUAMOUS CELL CARCINOMA;

AFRICAN AMERICANS; AGED; CARCINOMA, SQUAMOUS CELL; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED;

EID: 84867354968     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599812440681     Document Type: Conference Paper

References (40)

1. American Cancer Society. Cancer facts & figures2011. http://www.cancer.org/Research/CancerFactsFigures/CancerFactsFigures/ ACSPC-029771.
2. Hoffman HT, Karnell LH, Funk GF, et al. The National Cancer Data Base report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg. 1998 ; 124: 951-962 (Pubitemid 28411496)
3. Shavers VL, Harlan LC, Winn D, et al. Racial/ethnic patterns of care for cancers of the oral cavity, pharynx, larynx, sinuses, and salivary glands. Cancer Metastasis Rev. 2003 ; 22: 25-38 (Pubitemid 36363511)
4. Arbes SJ, Olshan AF, Caplan DJ, et al. Factors contributing to the poorer survival of black Americans diagnosed with oral cancer (United States). Cancer Causes Control. 1999 ; 10: 513-523
5. Goodwin WJ, Thomas GR, Parker DF, et al. Unequal burden of head and neck cancer in the United States. Head Neck. 2008 ; 30: 358-371 (Pubitemid 351480753)
6. Gourin CG, Podolsky RH. Racial disparities in patients with head and neck squamous cell carcinoma. Laryngoscope. 2006 ; 116: 1093-1106 (Pubitemid 44317932)
7. Murdock JM, Gluckman JL. African-American and white head and neck carcinoma patients in a university medical center setting. Are treatments provided and are outcomes similar or disparate?. Cancer. 2001 ; 91: 279-283
8. Settle K, Posner MR, Schumaker LM, et al. Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. Cancer Prev Res (Phila Pa). 2009 ; 2: 776-781
9. Hashibe M, Brennan P, Benhamou S, et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst. 2007 ; 99: 777-789 (Pubitemid 47073524)
10. Gillison ML, Lowy DR. A causal role for human papillomavirus in head and neck cancer. Lancet. 2004 ; 363: 1488-1489
11. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010 ; 363: 24-35
12. Wiencke JK. Impact of race/ethnicity on molecular pathways in human cancer. Nat Rev Cancer. 2004 ; 4: 79-84 (Pubitemid 38082156)
13. Piccirillo JF, Costas I, Claybour P, et al. The measurement of comorbidity by cancer registries. J Reg Manage. 2003 ; 30: 8-14
14. Naqvi K, Garcia-Manero G, Sardesai S, et al. Association of comorbidities with overall survival in myelodysplastic syndrome: development of a prognostic model. J Clin Oncol. 2011 ; 29: 2240-2246
15. Chen K, Sawhney R, Khan M, et al. Methylation of multiple genes as diagnostic and therapeutic markers in primary head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2007 ; 133: 1131-1138 (Pubitemid 350157026)
16. Worsham MJ, Pals G, Schouten JP, et al. Delineating genetic pathways of disease progression in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2003 ; 129: 702-708 (Pubitemid 36858953)
17. Worsham MJ, Chen KM, Tiwari N, et al. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2006 ; 132: 409-415
18. Worsham MJ, Pals G, Schouten JP, et al. High-resolution mapping of molecular events associated with immortalization, transformation, and progression to breast cancer in the MCF10 model. Breast Cancer Res Treat. 2006 ; 96: 177-186
19. Kunjoonju JP, Raitanen M, Grenman S, et al. Identification of individual genes altered in squamous cell carcinoma of the vulva. Genes Chromosomes Cancer. 2005 ; 44: 185-193 (Pubitemid 41306647)
20. Siegel RWE, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011 ; 61: 212-236
21. American Cancer Society. Cancer facts & figures for African Americans 2011-2012. http://www.cancer.org/Research/CancerFactsFigures/ CancerFactsFiguresforAfricanAmericans/cancer-facts-figures-african-american- 2011-2012.
22. Ward E, Halpern M, Schrag N, et al. Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin. 2008 ; 58: 9-31
23. Bach PB, Schrag D, Brawley OW, et al. Survival of blacks and whites after a cancer diagnosis. JAMA. 2002 ; 287: 2106-2113 (Pubitemid 34437345)
24. Long SA, D'Antonio LL, Robinson EB, et al. Factors related to quality of life and functional status in 50 patients with head and neck cancer. Laryngoscope. 1996 ; 106: 1084-1088 (Pubitemid 26304596)
25. MMWR Morb Mortal Wkly Rep. 2002 ; 51: 300-303
26. Brandwein-Gensler M, Teixeira MS, Lewis CM, et al. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol. 2005 ; 29: 167-178 (Pubitemid 40170634)
27. Hiratsuka H, Miyakawa A, Nakamori K, et al. Multivariate analysis of occult lymph node metastasis as a prognostic indicator for patients with squamous cell carcinoma of the oral cavity. Cancer. 1997 ; 80: 351-356 (Pubitemid 27323403)
28. Kurokawa H, Yamashita Y, Murata T, et al. Histological grading of malignancy correlates with regional lymph node metastasis and survival of patients with oral squamous cell carcinoma. Fukuoka Igaku Zasshi. 1998 ; 89: 225-231
29. Silva TA, Ribeiro FL, Oliveira-Neto HH, et al. Dual role of CCL3/CCR1 in oral squamous cell carcinoma: implications in tumor metastasis and local host defense. Oncol Rep. 2007 ; 18: 1107-1113
30. JohnsonG. Cancer's secrets come into sharper focus. New York Times. 2011. http://www.nytimes.com/2011/08/16/health/16cancer.html?pagewanted=all.
31. Folkman J. Angiogenesis. Annu Rev Med. 2006 ; 57: 1-18 (Pubitemid 43261975)
32. Haber DA. Splicing into senescence: the curious case of p16 and p19ARF. Cell. 1997 ; 91: 555-558 (Pubitemid 27513645)
33. Xing EP, Nie Y, Song Y, et al. Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma. Clin Cancer Res. 1999 ; 5: 2704-2713 (Pubitemid 29493943)
34. Lydiatt WM, Davidson BJ, Schantz SP, et al. 9p21 deletion correlates with recurrence in head and neck cancer. Head Neck. 1998 ; 20: 113-118 (Pubitemid 28106222)
35. Reed AL, Califano J, Cairns P, et al. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res. 1996 ; 56: 3630-3633 (Pubitemid 26272001)
36. Yarbrough WG. The ARF-p16 gene locus in carcinogenesis and therapy of head and neck squamous cell carcinoma. Laryngoscope. 2002 ; 112: 2114-2128 (Pubitemid 35417032)
37. Namazie A, Alavi S, Olopade OI, et al. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors. Laryngoscope. 2002 ; 112: 472-481 (Pubitemid 34225863)
38. Psyrri A, DiMaio D. Human papillomavirus in cervical and head-and-neck cancer. Nat Clin Pract Oncol. 2008 ; 5: 24-31 (Pubitemid 351512426)
39. Proost P, Wuyts A, van Damme J. The role of chemokines in inflammation. Int J Clin Lab Res. 1996 ; 26: 211-223
40. Yang X, Lu P, Fujii C, et al. Essential contribution of a chemokine, CCL3, and its receptor, CCR1, to hepatocellular carcinoma progression. Int J Cancer. 2006 ; 118: 1869-1876